ZLSCF (ZYUS Life Sciences) Inventories, Other: $0.14 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ZLSCF ZYUS Life Sciences Corp ZLSCF
21 GF Score
Price $0.60
! 6 Warning Signs
View Full Analysis

What is ZYUS Life Sciences Inventories, Other?

ZYUS Life Sciences ZLSCF -6.89% 21 Inventories, Other is $0.14 Mil as of Jun. 2026. GuruFocus rates ZLSCF with a GF Score™ of 21/100. The stock has 6 warning signs investors should review.

Other inventories including goods for resale, stocks in transit, consignment stocks, etc. ZYUS Life Sciences's other inventories for the quarter that ended in Jun. 2026 was $0.14 Mil.

ZYUS Life Sciences's quarterly other inventories increased from Dec. 2025 ($-0.00 Mil) to Mar. 2026 ($0.18 Mil) but then declined from Mar. 2026 ($0.18 Mil) to Jun. 2026 ($0.14 Mil).

ZYUS Life Sciences's annual other inventories declined from Dec. 2023 ($0.00 Mil) to Dec. 2024 ($0.00 Mil) and declined from Dec. 2024 ($0.00 Mil) to Dec. 2025 ($-0.00 Mil).

ZYUS Life Sciences Inventories, Other Historical Data

* Premium members only.

The historical data trend for ZYUS Life Sciences's Inventories, Other can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ZYUS Life Sciences Inventories, Other Chart

ZYUS Life Sciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Inventories, Other
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 -0.00

ZYUS Life Sciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Inventories, Other Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.40 0.33 -0.00 0.18 0.14
ZLSCF
21GF Score
ZYUS Life Sciences Corp ZLSCF
Inventories, Other is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ZYUS Life Sciences Inventories, Other Calculation

Other inventories including goods for resale, stocks in transit, consignment stocks, etc.

Frequently Asked Questions Learn more about Inventories, Other →
What does a Inventories, Other of $0.14 Mil mean?
ZYUS Life Sciences (ZLSCF) has a Inventories, Other of $0.14 Mil as of Jun. 2026. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on ZYUS Life Sciences and its competitors.
Is ZYUS Life Sciences' Inventories, Other too high?
ZYUS Life Sciences' current Inventories, Other is $0.14 Mil. Overall, ZYUS Life Sciences has a GF Score™ of 21/100, reflecting its overall financial health beyond just this single metric.
How does ZYUS Life Sciences' Inventories, Other compare to SKYI and CBDY?
ZYUS Life Sciences' Inventories, Other of $0.14 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Inventories, Other for a Drug Manufacturers company?
A good Inventories, Other depends on the Drug Manufacturers industry context. However, Inventories, Other should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Inventories, Other mean?
A high Inventories, Other can signal that a stock is expensive relative to its fundamentals. Other inventories a company records on its balance sheet, like goods for resale and stocks in transit. View historical data on ZYUS Life Sciences and its competitors. ZYUS Life Sciences's current Inventories, Other is $0.14 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ZYUS Life Sciences stock overvalued right now?
ZYUS Life Sciences (ZLSCF) has a current Inventories, Other of $0.14 Mil. The current Inventories, Other is $0.14 Mil. ZYUS Life Sciences' overall GF Score™ is 21/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Inventories, Other calculated?
Inventories, Other is calculated from a company's financial statements. For ZYUS Life Sciences (ZLSCF), the current Inventories, Other is $0.14 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ZYUS Life Sciences Business Description

Other Exchanges ZYUS:Canada
Address 407 Downey Road, Unit 204, Saskatoon, SK, CAN, S7N 4L8
ZYUS Life Sciences Corp is a Canadian biopharmaceutical company focused on developing and commercializing cannabinoid-based therapeutics and pharmaceutical-grade cannabinoid products. Through its licensed production facilities in Canada, the company produces medical cannabis and derivative products, including oils and other formulations, and pursues clinical development programs targeting pain, inflammation, and other therapeutic areas. Its product candidates are developed for healthcare professionals and patients in regulated medical markets. ZYUS generates revenue primarily through the sale of medical cannabis and cannabinoid-based products, alongside licensing and research collaborations. The company serves markets in Canada, the United States, Australia, and the European Union, positioning itself at the intersection of cannabis production and pharmaceutical drug development.
21GF Score

Get the complete analysis for ZLSCF

Inventories, Other is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.60
Price